Studying Diabetes and Quality of Life in Adults With Cystic Fibrosis
Observes how diabetes affects breathing and nutrition in adults with cystic fibrosis.
Plain-language title generated from the registry record
Registry title: Characterisation of a Population of Adults Suffering From Cystic Fibrosis in a Belgian Reference Center
Key facts
- Where
- Brussels, BelgiumSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with cystic fibrosis who are followed at one Belgian reference center. It studies how diabetes affects their quality of life, breathing and nutrition.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Confirmed diagnosis of cystic fibrosis
Main reasons for not taking part
- Refusing to take part
- Not being able to complete the quality-of-life questionnaires
Read by machine on 9 November 2026.
Where in Belgium
- Hôpital Erasme - HUB 808 route de Lennik 1070 Brussels BelgiumBrussels, BelgiumNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Erasme University Hospital
- Trial code
- NCT07442682
- Record updated
- 2 March 2026
- Original description
This research project aims to better understand the consequences of diabetes on the quality of life, respiratory function, and nutritional status of patients with cystic fibrosis followed at a Belgian reference center and to compare the quality of life of patients with cystic fibrosis depending on whether or not they have diabetes.Read full original descriptionShow less
Characterisation of a Population of Adults Suffering From Cystic Fibrosis in a Belgian Center of Reference and Evaluation of the Impact of Diabetes and CFTR Modulators on Respiratory Function, Nutritional Status and Quality of Life
This research project aims to better understand the consequences of diabetes on the quality of life, respiratory function, and nutritional status of patients with cystic fibrosis followed at a Belgian reference center and to compare the quality of life of patients with cystic fibrosis depending on whether or not they have diabetes.
Inclusion: Adults ≥18 years Confirmed diagnosis of cystic fibrosis Followed at the participating CF reference center Ability to complete quality-of-life questionnaires Signed informed consent (if required by EC); -.
Exclusion: Refusal to participate Inability to complete questionnaires.